MELBOURNE, Australia, July 2, 2020 /PRNewswire/ -- Melbourne-based Affinity Biosciences Pty Ltd (Af...
MELBOURNE, Australia and SAN FRANCISCO, June 29, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: A...
MELBOURNE, Austrilia and SAN FRANCISCO, May 21, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: AT...
Highlights: * European Commission designated Orphan Drug status for ATH434's treatment of Multip...
MELBOURNE, Australia and SAN FRANCISCO, Feb. 7, 2020 /PRNewswire/ -- Alterity Therapeutics Limited ...